Fixed-dose combinations: A valuable tool to improve adherence to antihypertensive treatment

Affiliations

Comment

Sarantis Satsoglou et al. J Clin Hypertens (Greenwich). 2018 May.

. 2018 May;20(5):908-909.

doi: 10.1111/jch.13299. Epub 2018 Apr 27.

¹ First Propedeutic Department of Internal Medicine, Medical School, AHEPA Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.

No abstract available

Comment on

The impact of fixed-dose combination versus free-equivalent combination therapies on adherence for hypertension: a meta-analysis.
Du LP, Cheng ZW, Zhang YX, Li Y, Mei D. Du LP, et al. J Clin Hypertens (Greenwich). 2018 May;20(5):902-907. doi: 10.1111/jch.13272. Epub 2018 Apr 27. J Clin Hypertens (Greenwich). 2018. PMID: 29700923 Free PMC article.

1. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Age‐specific relevance of usual blood pressure to vascular mortality: a meta‐analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360:1903‐1913. - PubMed
1. O'Donnell MJ, Xavier D, Liu L, et al. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case‐control study. Lancet. 2010;376:112‐123. - PubMed
1. Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case‐control study. Lancet. 2004;364:937‐952. - PubMed
1. Law MR, Morris JK, Wald NJ. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta‐analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ. 2009;338:b1665. - PMC - PubMed
1. Egan BM, Zhao Y, Axon RN. US trends in prevalence, awareness, treatment, and control of hypertension, 1988‐2008. JAMA. 2010;303:2043‐2050. - PubMed